ProCE Banner Activity

Near Future Directions: Promising Agents and Combinations Under Investigation

Slideset

Download these slides from our ASH 2020 live satellite symposium on CLL to review promising agents and combination therapies currently under investigation in CLL.

Released: December 04, 2020

Expiration: December 03, 2021

Share

Faculty

William G. Wierda

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmacyclics AbbVie

Janssen administered by Scientific Affairs

Lilly

Faculty Disclosure

Primary Author

William G. Wierda, MD, PhD

Associate Professor of Medicine
Department of Leukemia
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas

William G. Wierda, MD, PhD, has disclosed that he has received funds for research support from AbbVie, Acerta, Cyclacel, Genentech, Gilead Sciences, Janssen, Juno, Kite, Loxo, miRagen, Novartis, Oncternal, Pharmacyclics, Sunesis, and Xencor.